Quality of life of patients with cutaneous leishmaniasis: A comparative analysis of the EQ-5D-3L and CLIQ questionnaires
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0298988 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Endi Lanza Galvão und 5 weiteren Autor:innen. Beteiligte Einrichtung: Núcleo de Avaliação de Tecnologias em Saúde, Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, State of Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Quality of Life, Leishmaniasis, Cutaneous. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Projeto Inovação Fiocruz, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Purpose
To evaluate the performance of the Cutaneous Leishmaniasis Impact Questionnaire (CLIQ) using the EuroQol-5 Dimension (EQ-5D-3L) as a reference standard (criterion validation); to evaluate the responsiveness of the instruments and estimate a cut-off point for the CLIQ to be able to discriminate between high and low impacts of cutaneous leishmaniasis on patients.
Methods
Between 2020 and 2022, a longitudinal validation study was conducted at a reference centre for leishmaniasis in Brazil. The EQ-5D-3L and CLIQ questionnaires were administered before, during and after treatment for cutaneous leishmaniasis. The correlation between the instruments was assessed using Spearman’s correlation coefficient, responsiveness was assessed using the Wilcoxon test, and CLIQ cut-off points were proposed based on results of the EQ-5Q-3L, dichotomized between patients reporting no problems’ and ’some or extreme problems’.
Results
There were satisfactory correlation coefficients between the two instruments before (-0.596) and during treatment (-0.551) and a low correlation between the instruments after the end of treatment (-0.389). In general, the responsiveness of the instruments was satisfactory. The CLIC scores that maximized sensitivity and specificity for recognizing impaired health status before and during treatment were 7 points and 17 points, respectively. However, at the end of treatment, based on the results for the EQ-5D-3L, the CLIC was not able to discriminate between individuals with high and low impacts of the disease.
Conclusion
The CLIQ corresponds well with the EQ-5D-3L when applied before and during treatment but does not seem to be appropriate for follow-up evaluations after the end of treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Núcleo de Avaliação de Tecnologias em Saúde, Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, State of Minas Gerais, Brazil.
- Departamento de Fisioterapia, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, State of Minas Gerais, Brazil.
- Centro Federal de Educação Tecnológica de Minas Gerais, Contagem, State of Minas Gerais, Brazil.
ORCID-Profile: Endi Lanza Galvão, Janaína de Pina Carvalho
Förderung
- Projeto Inovação Fiocruz
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Galvão, E. L., de Pina Carvalho, J., Machado de Assis, T. S., Freire, M. L., Cota, G., & Nascimento Silva, S. (2024). Quality of life of patients with cutaneous leishmaniasis: A comparative analysis of the EQ-5D-3L and CLIQ questionnaires. PLOS ONE. https://doi.org/10.1371/journal.pone.0298988
Vancouver
Galvão EL, de Pina Carvalho J, Machado de Assis TS, Freire ML, Cota G, Nascimento Silva S. Quality of life of patients with cutaneous leishmaniasis: A comparative analysis of the EQ-5D-3L and CLIQ questionnaires. PLOS ONE. 2024. doi:10.1371/journal.pone.0298988
BibTeX
@article{Galvo2024,
author = {Galvão, Endi Lanza and de Pina Carvalho, Janaína and Machado de Assis, Tália Santana and Freire, Mariana Lourenço and Cota, Gláucia and Nascimento Silva, Sarah},
title = {Quality of life of patients with cutaneous leishmaniasis: A comparative analysis of the EQ-5D-3L and CLIQ questionnaires},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0298988}
}
EUVIMED